| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.024 | 0.9 |